> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Latest FDA Warning Letters
- URL: https://www.fdaweb.com/latest-fda-warning-letters-19/
- Published: 2020-04-12T12:00:00.000Z
- Updated: 2026-09-14T16:10:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5146555

[**Notice Corrected on ANDA Approval Withdrawals**](https://www.fdaweb.com/notice-corrected-on-anda-approval-withdrawals/)  
*Federal Register* notice: FDA corrects a 1/8 Federal Register notice that announced the withdrawal 23 ANDAs. 04/07/2020  

[**User Fee Report on Drug/Biosimilar Review Resources**](https://www.fdaweb.com/user-fee-report-on-drug-biosimilar-review-resources/)  
*Federal Register* notice: FDA posts a user fee-related report providing options and recommendations for a new methodology to assess changes in the resource and capacity needs for human drug and biosimilar biologic reviews. 04/07/2020  

[**Panel Review of GSK Trelegy Ellipta sNDA Postponed**](https://www.fdaweb.com/panel-review-of-gsk-trelegy-ellipta-snda-postponed/)  
*Federal Register* notice: FDA postpones a 4/21-planned Pulmonary-Allergy Drugs Advisory Committee meeting that was scheduled to discuss a GlaxoSmithKline supplemental NDA for Trelegy Ellipta. 04/07/2020  

[**Info Collection on Service Delivery Feedback**](https://www.fdaweb.com/info-collection-on-service-delivery-feedback/)  
*Federal Register* notice: FDA seeks comments on an information collection extension for “Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery.” 04/06/2020  

[**Info Collection on Cell, Tissue Product Registration**](https://www.fdaweb.com/info-collection-on-cell-tissue-product-registration/)  
*Federal Register* notice: FDA sends to OMB an information collection extension for “Human Cells, Tissues, and Cellular and Tissue-Based Products: Establishment Registration and Listing; Eligibility Determination for Donors; and Current Good Tissue Practice.” 04/06/2020  

[**Device User Fee Reauthorization Meeting 5/5**](https://www.fdaweb.com/device-user-fee-reauthorization-meeting-5-5/)  
*Federal Register* notice: FDA reschedules for 5/5 its public meeting entitled “Medical Device User Fee Amendments for Fiscal Years 2023 Through 2027.” 04/06/2020  

[**Info Collection on Dietary Supplement GMPs**](https://www.fdaweb.com/info-collection-on-dietary-supplement-gmps/)  
*Federal Register* notice: FDA sends to OMB an information collection revision entitled “Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements — 21 CFR Part 111.” 04/03/2020  

[**Info Collection on FOIA Identity Certification**](https://www.fdaweb.com/info-collection-on-foia-identity-certification/)  
*Federal Register* notice: FDA sends to OMB an information collection extension for “Certification of Identity; Form FDA 3975.” 04/03/2020